Yatharth Hospital & Trauma Care Services Limited has scheduled its 19th Annual General Meeting (AGM) for Friday, September 25, 2026. The meeting will commence at 12:00 noon and will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM).

The company issued the intimation on August 22, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. The session aims to address routine corporate governance matters in compliance with the Companies Act, 2013.

Meeting Details

The AGM will be held virtually to ensure accessibility for all shareholders. The company confirmed that the Notice of AGM, along with the Annual Report, will be dispatched to members in due course. This process adheres to the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.

Regulatory Compliance

The disclosure was made to the National Stock Exchange of India Limited and BSE Limited. The information is also available on the company’s investor relations website. Ritesh Mishra, Company Secretary and Compliance Officer, signed the communication on behalf of the board.

Corporate Information

The company operates multiple hospitals across Uttar Pradesh, Madhya Pradesh, Haryana, and New Delhi. Shareholders are advised to monitor official communications for the dispatch of the annual report.

Yatharth Hospital & Trauma Care Services Limited reported its highest-ever quarterly revenue of ₹3,927 million for Q1FY27, marking a 51% increase year-on-year and a 15% rise quarter-on-quarter. The robust top-line growth was accompanied by an EBITDA expansion of 39% to ₹917 million, with net profit (PAT) reaching ₹454 million. The performance underscores the successful integration of newer assets and improved operational leverage across the group's hospital network.

Financial Performance

The financial results for the quarter ended June 30, 2026, reflect a significant shift in revenue mix, with newer hospitals contributing substantially to the bottom line. While existing hospitals in Noida and Jhansi-Orchha delivered steady growth, the newer facilities in Greater Faridabad, New Delhi, Faridabad Sector 20, and Agra accounted for 27% of the total group revenue.

The adjusted EBITDA margin, excluding the impact of the New Delhi and Faridabad Sector 20 hospitals, stood at 28.1%. The overall consolidated EBITDA margin was 23.3%, reflecting the initial ramp-up phase of recent acquisitions. Management noted that while depreciation and finance costs increased due to capacity additions over the past 12 months, cash profit (PAT plus depreciation) grew by 32% year-on-year.

Operational Highlights & Capacity Expansion

Yatharth Hospital’s average revenue per occupied bed (ARPOB) reached an all-time high of ₹34,758, up 7% from the previous year. Premium NCR hospitals, including Noida Extension and New Delhi, crossed the ₹50,000 ARPOB mark for the first time, signaling an improving case mix. Greater Noida achieved an ARPOB of ₹43,000, while Faridabad Sector 20 approached ₹40,000.

Occupancy levels at the established Noida and Jhansi-Orchha hospitals remained strong at over 90%. The group’s total bed capacity has expanded to 2,555 beds, with plans to reach over 3,200 beds soon through brownfield expansions in Noida Extension and Greater Noida, alongside the upcoming Gurugram facility. The Gurugram hospital, featuring 250 beds, is expected to go live by Q1 of the next fiscal year.

Newer Hospitals Performance

The acquisition strategy has shown early success, with newer hospitals collectively contributing ₹1,067 million in revenue. Key operational milestones include:

• Faridabad Sector 20: Achieved EBITDA breakeven within nine months, contributing ₹12–13 crore monthly revenue.
• New Delhi: Operating at a monthly revenue run rate of ₹8 crore with an ARPOB nearing ₹50,000.
• Agra: Delivered a 20%+ EBITDA margin in its first full quarter of integration, with a revenue run rate of ₹9–10 crore.

Strategic Initiatives & Outlook

In recognition of the strong performance, the Board approved a maiden interim dividend of 5% of face value for all shareholders. Additionally, the company launched a new ESOP scheme for 2026 to attract and retain talent. Yatharth Hospital also expanded its international outreach by opening an information center in Uzbekistan and initiating OPD programs in Asia, Africa, and the Middle East.

Looking ahead, management reaffirmed its roadmap to double bed capacity to 5,000 beds within the next few years, primarily focusing on North India and metro cities. The company expects to maintain revenue growth above last year’s 37% YoY rate, with full-year FY27 EBITDA margins targeted at upwards of 24%. ARPOB growth is estimated at 9%–10% for the fiscal year.

What the Numbers Show

The divergence between the consolidated EBITDA margin (23.3%) and the adjusted margin excluding new assets (28.1%) highlights the significant drag from recently acquired hospitals still in their ramp-up phase. However, the rapid breakeven of Faridabad Sector 20 within nine months suggests that this drag will diminish quickly as these assets mature. The simultaneous rise in ARPOB (+7%) and occupancy (~75%) indicates that growth is being driven by both volume and value, rather than just capacity addition, supporting the sustainability of the margin expansion trajectory.